Sonendo, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OTC.Pink
SONX
Sonendo, INCSonendo, Inc. has entered into an amendment to its credit agreement, deferring and waiving certain amortization payments contingent upon successful equity financings.
OTC.Pink
SONX
Sonendo, INCSonendo, Inc. announced a significant reduction in operating losses and free cash flow burn for the third quarter of 2024, despite a slight decrease in revenue.
OTC.Pink
SONX
Sonendo, INCSonendo, Inc. was not the winning bidder in the bankruptcy auction for Biolase assets and will receive a break-up fee and expense reimbursement.
OTC.Pink
SONX
Sonendo, INCSonendo, Inc. has executed a 1-for-200 reverse stock split, effective October 18, 2024, to consolidate its shares and potentially improve its stock price.
OTC.Pink
SONX
Sonendo, INCSonendo reports preliminary Q3 2024 revenue between $7.9 and $8.0 million and increases its full-year 2024 revenue guidance.
OTC.Pink
SONX
Sonendo, INCSonendo, Inc. has entered into an asset purchase agreement to acquire certain assets of Biolase, Inc. and its subsidiaries related to dental laser systems for $14 million in cash, assumption of liabilities, and the value of a pending litigation.
OTC.Pink
SONX
Sonendo, INCSonendo, Inc. is considering a stalking horse bid for the assets of Biolase, Inc., which is potentially facing bankruptcy.
OTC.Pink
SONX
Sonendo, INCSonendo Inc. reports the resignation of its Chief Talent Officer, Roy T. Chen, effective September 6, 2024, with the Human Resources function to be overseen by the CFO.
OTC.Pink
SONX
Sonendo, INCSonendo, Inc. has dismissed Ernst & Young LLP and appointed BDO USA, P.C. as its new independent registered public accounting firm, effective August 14, 2024.
OTC.Pink
SONX
Sonendo, INCSonendo Inc. reported improved financial results for the second quarter of 2024, including increased gross margins and a raised full-year revenue guidance.
OTC.Pink
SONX
Sonendo, INCSonendo, Inc. held its annual meeting on June 10, 2024, where stockholders elected directors, ratified the accounting firm, and approved a reverse stock split.
OTC.Pink
SONX
Sonendo, INCSonendo, a dental technology company, has appointed John Bostjancic as its new Chief Financial Officer, effective June 5, 2024, as part of a broader leadership restructuring.
OTC.Pink
SONX
Sonendo, INCSonendo reported first quarter 2024 revenue of $7.0 million, exceeding prior guidance, and announced a strategic reset of its commercial and operational priorities.
OTC.Pink
SONX
Sonendo, INCSonendo Inc. has withdrawn its appeal against delisting from the New York Stock Exchange, and its common stock is now trading on the OTCQX market.
OTC.Pink
SONX
Sonendo, INCSadie Stern, a director at Sonendo, Inc., will not seek reelection at the 2024 Annual Meeting of Stockholders, concluding her service on the board and its committees.
OTC.Pink
SONX
Sonendo, INCSonendo Inc. has amended the compensation package for its Interim Chief Financial Officer, Chris Guo, including a base salary, bonus eligibility, and a retention bonus.
OTC.Pink
SONX
Sonendo, INCSonendo's full-year 2023 revenue grew by 5% to $43.9 million, while the company also divested its TDO software segment and restructured its debt.
OTC.Pink
SONX
Sonendo, INCSonendo, Inc. has announced the resignation of its Chief Financial Officer, Michael P. Watts, effective March 15, 2024, and the appointment of Chris Guo as Interim CFO.
OTC.Pink
SONX
Sonendo, INCSonendo divests its TDO Software business for $16 million and amends its credit agreement to include a $15 million principal repayment.
OTC.Pink
SONX
Sonendo, INCKaren McGinnis has resigned from Sonendo's Board of Directors and its Audit and Compensation Committees, effective March 31, 2024.